{"id":"W2948436219","doi":"10.1056/nejmoa1815281","title":"Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; Novo Nordisk Fonden","keywords":"Venetoclax; Obinutuzumab; Medicine; Ibrutinib; Internal medicine; Oncology; Cancer research; Chronic lymphocytic leukemia; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004534493,0.00009933807,0.0003858301,0.0002014288,0.00002249882,0.000007150464,0.00004549238,0.0000460032,0.0001266131],"category_scores_gemma":[0.0002844133,0.00005989519,0.00001311378,0.0001382241,0.0001335854,0.0000783996,0.0000229548,0.0003147448,0.000002636991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00199569,"about_ca_system_score_gemma":0.00235783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000290956,"about_ca_topic_score_gemma":0.00003629606,"domain_scores_codex":[0.998903,0.00004110508,0.0003142961,0.0001171433,0.0004456042,0.000178873],"domain_scores_gemma":[0.9990492,0.0002746046,0.0001387775,0.0001105322,0.0001527275,0.0002741236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.006916377,0.00008183312,0.9465131,0.0004619482,0.00021129,0.0008464422,0.003251629,0.0001464462,0.0008275276,0.0003516377,0.003128237,0.03726356],"study_design_scores_gemma":[0.5194593,0.007028296,0.4587111,0.002544021,0.0001411203,0.002646723,0.0003588781,0.001463315,0.0000464601,0.000297033,0.00717483,0.0001288885],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971331,0.0006320113,0.00001255328,0.000675989,0.00009936753,0.0002317711,0.000001719065,0.000003916156,0.00120953],"genre_scores_gemma":[0.9986727,0.0001215706,0.0002082308,0.0002002961,0.0004650875,6.462957e-7,0.000007352952,0.00001241937,0.0003116541],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5125429,"threshold_uncertainty_score":0.521866,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009446074225422615,"score_gpt":0.2713665505737163,"score_spread":0.2619204763482937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}